𝔖 Bobbio Scriptorium

✦ LIBER ✦

O-81. Fulvestrant in pretreated patients with advanced breast cancer: experience from the Institut Bergoni

Book ID: 118622507
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 108 KB
Volume: 3
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(05)80081-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

445 PUBLICATION Fulvestrant in heavily p

445 PUBLICATION Fulvestrant in heavily pretreated patients with advanced breast cancer: experience from a Named Patient Programme in Switzerland

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Fulvestrant (‘Faslodex’) in heavily pret

Fulvestrant (‘Faslodex’) in heavily pretreated postmenopausal patients with advanced breast cancer: single centre clinical experience from the compassionate use programme

✍ Brigitte Mlineritsch; Oskar Psenak; Peter Mayer; Martin Moik; Konrad Namberger; 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 300 KB

Activity of fulvestrant versus exemestan

Activity of fulvestrant versus exemestane in advanced breast cancer patients with or without visceral metastases: data from the EFECT trial

✍ Louis Mauriac; Gilles Romieu; José Bines 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 235 KB

A single-institution experience from the

A single-institution experience from the Lapatinib Expanded Access Program – effect of lapatinib and capecitabine combination therapy on CNS metastases in patients with ErbB2+ metastatic breast cancer

✍ B. Kaufman; R. Weitzen; A. Goldfarb; N. Ephrat; I. Kuchuk; T. Golan; I. Wolf; R. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Randomised controlled trial comparing si

Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the ‘Mario Negri’ Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group

✍ Buda, A; Floriani, I; Rossi, R; Colombo, N; Torri, V; Conte, P F; Fossati, R; Ra 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

Letter to the Editor regarding manuscrip

Letter to the Editor regarding manuscript entitled: Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution. Grabau D, Dihge L, Ferno M, Ingvar C, Ryden L. Eur J Surg Oncol. 2013 Jun;39(6):601–7

✍ Kirwan, C.C.; Debnath, D.; Howe, M.C.; Johnson, R.K.; Bundred, N.J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 90 KB